Global transplant reach Immucor serves thousands of hospitals, reference laboratories, and donor centers worldwide, presenting multiple entry points for partnerships across diverse healthcare systems and geographies.

End-to-end portfolio From traditional reagents to automated instruments and software, there are multiple sales opportunities to cross-sell or upsell integrated lab solutions that improve throughput and standardization.

Innovation pipeline Recent launches in NGS-based HLA typing software, epitope matching pipelines, and partnerships indicate a strong emphasis on advanced diagnostics that can be offered as upgraded platforms or add-ons.

Security and compliance Updated cybersecurity policies and enterprise-grade software solutions position Immucor as a partner for labs prioritizing data security, enabling collaborations around compliant digital workflows.

Growth through automation A focus on automation and software-driven optimization suggests opportunities to bundle hardware with software to enhance efficiency, accuracy, and patient access to safe transfusion and transplantation services.